Moreover, the deletion includes the PRKAG2 gene, implicated in a nonsarcomeric form of hypertrophic cardiomyopathy, associated with accessory pathway, short PR, and late evidence of supraventricular and ventricular tachycardia, complete heart block, and sudden death. Here, PRKAG2 is linked to hypertrophic cardiomyopathy.